Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 61

The DOI matches its Crossref record.

Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literature

Lebrun-Vignes, B., Kreft-Jais, C., Castot, A., Chosidow, O., the French Network of Regional Centers of Pharmacovigilance·2012·British Journal of Dermatology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2133.2012.10845.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 115

  1. Gaujoux-Viala, 2010, Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis, Ann Rheum Dis, 69, 1004, 10.1136/ard.2009.127225 · DOI · Paper page
  2. Doherty, 2008, Evidence-based therapy for cutaneous sarcoidosis, Drugs, 68, 1361, 10.2165/00003495-200868100-00003 · doi:10.2165/00003495-200868100-00003
  3. Plane, 2010, Prospects for minocycline neuroprotection, Arch Neurol, 67, 1442, 10.1001/archneurol.2010.191 · DOI · Paper page
  4. Begon, 2004, [Drug hypersensitivity syndrome: DRESS (drug reaction with eosinophilia and systemic symptoms)], Ann Dermatol Venereol, 131, 293, 10.1016/S0151-9638(04)93600-9 · doi:10.1016/s0151-9638(04)93600-9
  5. Smith, 2005, Safety of doxycycline and minocycline: a systematic review, Clin Ther, 27, 1329, 10.1016/j.clinthera.2005.09.005 · DOI · Paper page
  6. Grasset, 2003, Cyclines and acne: pay attention to adverse drug reactions! A recent literature review, Rev Med Interne, 24, 305, 10.1016/S0248-8663(02)00017-6 · DOI
  7. Roberts, 2006, The frequency and distribution of minocycline induced hyperpigmentation in a rheumatoid arthritis population, J Rheumatol, 33, 1254
  8. Peyrière, 2006, Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?, Br J Dermatol, 155, 422, 10.1111/j.1365-2133.2006.07284.x · DOI · Paper page
  9. Maubec, 2008, Minocycline-induced DRESS: evidence for accumulation of the culprit drug, Dermatology, 216, 200, 10.1159/000112926 · doi:10.1159/000112926
  10. Margolis, 2007, Association or lack of association between tetracycline class antibiotics used for acne vulgaris and lupus erythematosus, Br J Dermatol, 157, 540, 10.1111/j.1365-2133.2007.08056.x · DOI
  11. Marzo-Ortega, 2007, Is minocycline therapy in acne associated with antineutrophil cytoplasmic antibody positivity? A cross-sectional study, Br J Dermatol, 156, 1005, 10.1111/j.1365-2133.2007.07828.x · doi:10.1111/j.1365-2133.2007.07828.x
  12. Lim, 2003, High-level ultraviolet A photoprotection is needed to prevent doxycycline phototoxicity: lessons learned in East Timor, Br J Dermatol, 149, 213, 10.1046/j.1365-2133.2003.05389.x · DOI
  13. Heaton, 2007, Association between tetracycline or doxycycline and hepatotoxicity: a population based case-control study, J Clin Pharm Ther, 32, 483, 10.1111/j.1365-2710.2007.00853.x · DOI
  14. El-Hallak, 2008, Chronic minocycline-induced autoimmunity in children, J Pediatr, 153, 314, 10.1016/j.jpeds.2008.03.013 · DOI
  15. Gait, 2008, Perinuclear antineutrophilic cytoplasmic antibody-positive polyarteritis nodosa secondary to minocycline treatment for acne vulgaris, J Am Acad Dermatol, 58, S123, 10.1016/j.jaad.2007.05.032 · doi:10.1016/j.jaad.2007.05.032
  16. Ford, 2008, Minocycline hepatitis, Eur J Gastroenterol Hepatol, 20, 796, 10.1097/MEG.0b013e3282f493c5 · DOI
  17. Ahmed, 2008, Lupus syndrome with neutropenia following minocycline therapy - a case report, Int J Lab Hematol, 30, 543, 10.1111/j.1751-553X.2007.00967.x · doi:10.1111/j.1751-553x.2007.00967.x
  18. Geddes, 2007, Minocycline-induced lupus in adolescents: clinical implications for physical therapists, J Orthop Sports Phys Ther, 37, 65, 10.2519/jospt.2007.2312 · doi:10.2519/jospt.2007.2312
  19. Tehrani, 2007, Minocycline-induced cutaneous polyarteritis nodosa, J Clin Rheumatol, 13, 146, 10.1097/RHU.0b013e3180690693 · doi:10.1097/rhu.0b013e3180690693
  20. Benjamin, 2007, Hyperthyroidism and lupus-like syndrome in an adolescent treated with minocycline for acne vulgaris, Pediatr Dermatol, 24, 246, 10.1111/j.1525-1470.2007.00395.x · DOI
  21. Leydet, 2006, Lupus induit par la minocycline, Rev Med Interne, 27, 72, 10.1016/j.revmed.2005.09.001 · doi:10.1016/j.revmed.2005.09.001
  22. Abad, 2006, Additional case of minocycline-induced cutaneous polyarteritis nodosa: comment on the article by Culver et al, Arthritis Rheum, 55, 831, 10.1002/art.22242 · doi:10.1002/art.22242
  23. Katada, 2006, Minocycline-induced vasculitis fulfilling the criteria of polyarteritis nodosa, Mod Rheumatol, 16, 256, 10.1007/s10165-006-0492-4 · doi:10.1007/s10165-006-0492-4
  24. Culver, 2005, Case report and review of minocycline-induced cutaneous polyarteritis nodosa, Arthritis Rheum, 53, 468, 10.1002/art.21186 · doi:10.1002/art.21186
  25. Egger, 2006, Minocycline-induced lupus erythematodes, Praxis (Bern), 95, 1297, 10.1024/0369-8394.95.35.1297 · doi:10.1024/0369-8394.95.35.1297
  26. Chamberlain, 2006, Minocycline-induced autoimmune hepatitis with subsequent cirrhosis, J Pediatr Gastroenterol Nutr, 42, 232, 10.1097/01.mpg.0000184923.47507.ae · doi:10.1097/01.mpg.0000184923.47507.ae
  27. Sethi, 2003, ANCA-positive crescentic glomerulonephritis associated with minocycline therapy, Am J Kidney Dis, 42, E27, 10.1016/S0272-6386(03)00671-1 · doi:10.1016/s0272-6386(03)00671-1
  28. Egiguren, 2007, Patient with autoimmune hepatitis and idiopathic thrombocytopenic purpura after minocycline therapy, Gastroenterol Hepatol, 30, 565, 10.1157/13111686 · DOI
  29. Fay, 2008, Minocycline-induced hyperpigmentation in rheumatoid arthritis, J Clin Rheumatol, 14, 17, 10.1097/RHU.0b013e31816356d1 · doi:10.1097/rhu.0b013e31816356d1
  30. Huq, 2008, Spurious bruising in a patient taking warfarin: minocycline-induced skin hyperpigmentation, J Am Geriatr Soc, 56, 1156, 10.1111/j.1532-5415.2008.01696.x · doi:10.1111/j.1532-5415.2008.01696.x
  31. Tacon, 2008, Drug-induced thyroiditis and papillary carcinoma in a minocycline-pigmented black thyroid gland, Thyroid, 18, 795, 10.1089/thy.2008.0048 · doi:10.1089/thy.2008.0048
  32. Soung, 2007, Case reports: minocycline-induced hyperpigmentation resolves during oral isotretinoin therapy, J Drugs Dermatol, 6, 1232
  33. Chatterjee, 2007, Hyperpigmentation associated with minocycline therapy, CMAJ, 176, 321, 10.1503/cmaj.060866 · doi:10.1503/cmaj.060866
  34. Madan, 2007, Minocycline-induced pigmentation of pre-existing capillaritis, Br J Dermatol, 156, 590, 10.1111/j.1365-2133.2007.07680.x · doi:10.1111/j.1365-2133.2007.07680.x
  35. Carman, 2006, Images in vascular medicine. Drug-related skin and atherosclerotic plaque pigmentation, Vasc Med, 11, 276, 10.1177/1358863x06073459 · doi:10.1177/1358863x06073459
  36. Bruins, 2007, Papillary thyroid carcinoma in a patient with sarcoidosis treated with minocycline, Neth J Med, 65, 185
  37. Ban, 2007, Nail discoloration occurring after 8 weeks of minocycline therapy, J Dermatol, 34, 699, 10.1111/j.1346-8138.2007.00362.x · doi:10.1111/j.1346-8138.2007.00362.x
  38. Bowen, 2007, The histopathology of subcutaneous minocycline pigmentation, J Am Acad Dermatol, 57, 836, 10.1016/j.jaad.2007.04.028 · doi:10.1016/j.jaad.2007.04.028
  39. Gerson, 2006, Black pigmentation of atherosclerotic plaques associated with chronic minocycline therapy, Cardiovasc Pathol, 15, 168, 10.1016/j.carpath.2005.11.002 · doi:10.1016/j.carpath.2005.11.002
  40. Rahman, 2005, Minocycline hyperpigmentation isolated to the subcutaneous fat, J Cutan Pathol, 32, 516, 10.1111/j.0303-6987.2005.00369.x · doi:10.1111/j.0303-6987.2005.00369.x
  41. Suwannarat, 2004, Minocycline-induced hyperpigmentation masquerading as alkaptonuria in individuals with joint pain, Arthritis Rheum, 50, 3698, 10.1002/art.20606 · doi:10.1002/art.20606
  42. Alkhatib, 2006, The tarnished tongue, Am J Med, 119, 832, 10.1016/j.amjmed.2006.07.031 · doi:10.1016/j.amjmed.2006.07.031
  43. Kalia, 2006, Dermacase. Minocycline-induced pigmentation, Can Fam Physician, 52, 595
  44. Treister, 2004, Oral mucosal pigmentation secondary to minocycline therapy: report of two cases and a review of the literature, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 97, 718, 10.1016/j.tripleo.2003.11.006 · doi:10.1016/j.tripleo.2003.11.006
  45. Anonymous, 2004, Pathologic quiz case: tumor in pigmented thyroid gland in a young man. Papillary thyroid carcinoma in a minocycline-induced, diffusely pigmented thyroid gland, Arch Pathol Lab Med, 128, 355, 10.5858/2004-128-355-PQCTIP · doi:10.5858/2004-128-355-pqctip
  46. Pantanowitz, 2003, Black thyroid, Ear Nose Throat J, 82, 676, 10.1177/014556130308200908 · doi:10.1177/014556130308200908
  47. Dodiuk-Gad, 2006, Minocycline-induced cutaneous hyperpigmentation: confocal laser scanning microscope analysis, J Eur Acad Dermatol Venereol, 20, 435, 10.1111/j.1468-3083.2006.01436.x · DOI
  48. Hepburn, 2005, Minocycline-induced black bone disease, Orthopedics, 28, 501, 10.3928/0147-7447-20050501-20 · doi:10.3928/0147-7447-20050501-20
  49. Patterson, 2004, Hyperpigmented scar due to minocycline therapy, Cutis, 74, 293
  50. Pandit, 2004, Black pigmentation of bone due to long-term minocycline use, Surgeon, 2, 236, 10.1016/S1479-666X(04)80008-8 · doi:10.1016/s1479-666x(04)80008-8
  51. LaPorta, 2005, Minocycline-associated intra-oral soft-tissue pigmentation: clinicopathologic correlations and review, J Clin Periodontol, 32, 119, 10.1111/j.1600-051X.2005.00646.x · DOI
  52. Damm, 2004, Blue palate and alveolar ridge, Gen Dent, 52, 554
  53. Alster, 2004, Minocycline-induced hyperpigmentation treated with a 755-nm Q-switched alexandrite laser, Dermatol Surg, 30, 1201, 10.1111/j.1524-4725.2004.30372.x · doi:10.1111/j.1524-4725.2004.30372.x
  54. Herbers, 2004, Bluish-grey pigmentation of fingernails, gingiva, teeth and peri-oral region. Minocycline, Neth J Med, 62, 58
  55. Hawfield, 2004, Trauma-induced cutaneous pigmentation from tetracycline: a case report, Pediatr Dermatol, 21, 164, 10.1111/j.0736-8046.2004.21216.x · doi:10.1111/j.0736-8046.2004.21216.x
  56. Mouton, 2004, A new type of minocycline-induced cutaneous hyperpigmentation, Clin Exp Dermatol, 29, 8, 10.1111/j.1365-2230.2004.01421.x · doi:10.1111/j.1365-2230.2004.01421.x
  57. McCleskey, 2004, Minocycline-induced blue-green discoloration of bone. A case report, J Bone Joint Surg Am, 86, 146, 10.2106/00004623-200401000-00023 · doi:10.2106/00004623-200401000-00023
  58. Shimizu, 2008, Case of acute eosinophilic pneumonia probably induced by minocycline, Nihon Kokyuki Gakkai Zasshi, 46, 136
  59. Brown, 2009, Minocycline-induced drug hypersensitivity syndrome followed by multiple autoimmune sequelae, Arch Dermatol, 145, 63, 10.1001/archdermatol.2008.521 · DOI
  60. Yamasawa, 2008, Case of minocycline-induced acute eosinophilic pneumonia accompanied by marked neutrophilia in the peripheral blood, Nihon Kokyuki Gakkai Zasshi, 46, 820
  61. Losanoff, 2007, Minocycline toxicity requiring liver transplant, Dig Dis Sci, 52, 3242, 10.1007/s10620-006-9550-1 · doi:10.1007/s10620-006-9550-1
  62. Ono, 2007, Minocycline-induced acute eosinophilic pneumonia: controversial results of lymphocyte stimulation test and re-challenge test, Intern Med, 46, 593, 10.2169/internalmedicine.46.6235 · doi:10.2169/internalmedicine.46.6235
  63. Favrolt, 2007, [Severe drug rash with eosinophilia and systemic symptoms after treatment with minocycline], Rev Mal Respir, 24, 892, 10.1016/S0761-8425(07)91393-5 · doi:10.1016/s0761-8425(07)91393-5
  64. Arai, 2007, [Case of minocycline-induced pneumonitis with bilateral pleural effusion], Arerugi, 56, 1293
  65. Muller, 2003, Drug hypersensitivity syndrome in a West-Indian population, Eur J Dermatol, 13, 478
  66. Dukic, 2004, Papulose lymphomatoïde atypique à grandes cellules supposée déclenchée par la minocycline, Rev Med Interne, 25, 397, 10.1016/j.revmed.2004.02.010 · doi:10.1016/j.revmed.2004.02.010
  67. Rikken, 2004, Interstitial pneumonia and hepatitis caused by minocycline, Neth J Med, 62, 62
  68. Hammerer, 2004, Alvéolite neutrophilique due à la minocycline?, Rev Pneumol Clin, 60, 46, 10.1016/S0761-8417(04)72083-0 · doi:10.1016/s0761-8417(04)72083-0
  69. Real Martinez, 2003, [Acute hepatitis and minocycline], Rev Esp Enferm Dig, 95, 741
  70. Bamberg, 2003, [Cutaneous xanthomas associated with minocycline-induced cholestatic jaundice], Hautarzt, 54, 864, 10.1007/s00105-003-0525-2 · doi:10.1007/s00105-003-0525-2
  71. Tsuruta, 2006, Drug hypersensitivity syndrome caused by minocycline, J Cutan Med Surg, 10, 131, 10.2310/7750.2006.00019 · doi:10.2310/7750.2006.00019
  72. Trivin, 2005, [Minocycline-induced drug hypersensitivity syndrome with hepatic disease], Therapie, 60, 590, 10.2515/therapie:2005084 · doi:10.2515/therapie:2005084
  73. Carlson, 2006, Adverse antibiotic-induced eruptions associated with Epstein-Barr virus infection and showing Kikuchi-Fujimoto disease-like histology, Am J Dermatopathol, 28, 48, 10.1097/01.dad.0000164604.56650.26 · DOI
  74. Lee, 2005, Cardiogenic shock and peripheral eosinophilia in a young woman, Ann Allergy Asthma Immunol, 95, 229, 10.1016/S1081-1206(10)61218-5 · DOI
  75. Hidalgo Correas, 2005, Minocycline-induced pleurocarditis and eosinophilic pneumonia: a propos of a case, Farm Hosp, 29, 145, 10.1016/S1130-6343(05)73652-7 · doi:10.1016/s1130-6343(05)73652-7
  76. Kesler, 2004, The outcome of pseudotumor cerebri induced by tetracycline therapy, Acta Neurol Scand, 110, 408, 10.1111/j.1600-0404.2004.00327.x · doi:10.1111/j.1600-0404.2004.00327.x
  77. Fukui, 2004, [Case of drug-induced pneumonia followed by sequential bronchoalveolar lavage], Nihon Kokyuki Gakkai Zasshi, 42, 743
  78. Grim, 2003, Late-onset drug fever associated with minocycline: case report and review of the literature, Pharmacotherapy, 23, 1659, 10.1592/phco.23.15.1659.31966 · DOI
  79. Heidrich, 2004, [Stomatitis, glossitis, and esophagitis in a patient treated with minocycline], Med Klin (Munich), 99, 396, 10.1007/s00063-004-1058-x · doi:10.1007/s00063-004-1058-x
  80. Cohen, 2004, Medication-associated depersonalization symptoms: report of transient depersonalization symptoms induced by minocycline, South Med J, 97, 70, 10.1097/01.SMJ.0000083857.98870.98 · DOI
  81. Ayaslioglu, 2005, Doxycycline-induced staining of permanent adult dentition, Aust Dent J, 50, 273, 10.1111/j.1834-7819.2005.tb00373.x · doi:10.1111/j.1834-7819.2005.tb00373.x
  82. Miller, 2006, Black thyroid resulting from short-term doxycycline use: case report, review of the literature, and discussion of implications, Head Neck, 28, 373, 10.1002/hed.20385 · doi:10.1002/hed.20385
  83. Akcam, 2005, Nail discoloration induced by doxycycline, Pediatr Infect Dis J, 9, 845, 10.1097/01.inf.0000177283.71692.56 · DOI
  84. Nelson, 2006, Doxycycline-induced staining of adult teeth: the first reported case, Arch Dermatol, 142, 1081, 10.1001/archderm.142.8.1081 · doi:10.1001/archderm.142.8.1081
  85. Volovitz, 2007, Absence of tooth staining with doxycycline treatment in young children, Clin Pediatr, 46, 121, 10.1177/0009922806290026 · DOI
  86. Heveling, 2007, Doxycycline-induced amnesia: a case report, Eur J Clin Pharmacol, 63, 95, 10.1007/s00228-006-0221-0 · doi:10.1007/s00228-006-0221-0
  87. Segelnick, 2008, Recognizing doxycycline-induced esophageal ulcers in dental practice: a case report and review, J Am Dent Assoc, 139, 581, 10.14219/jada.archive.2008.0218 · doi:10.14219/jada.archive.2008.0218
  88. Passalidou, 2006, Un cas d’ulcère oesophagien secondaire à la prise de doxycycline, Arch Pédiatr, 13, 90, 10.1016/j.arcped.2005.10.014 · doi:10.1016/j.arcped.2005.10.014
  89. Grgurevic, 2005, [Doxycycline induced esophageal ulcers: report of two cases and review of the literature], Lijec Vjesn, 127, 285
  90. Alonso Fernandez, 2005, [Oesophageal ulcer and doxycycline], Aten Primaria, 36, 224
  91. Valean, 2005, Pill esophagitis, Rom J Gastroenterol, 14, 159
  92. Pociello Alminana, 2005, Doxycycline-induced esophagitis: report of two cases, Ann Pediatr, 62, 171
  93. Kadayifci, 2004, Doxycycline-induced pill esophagitis, Dis Esophagus, 17, 168, 10.1111/j.1442-2050.2004.00384.x · doi:10.1111/j.1442-2050.2004.00384.x
  94. Gencosmanoglu, 2004, Mid-esophageal ulceration and candidiasis-associated distal esophagitis as two distinct clinical patterns of tetracycline or doxycycline-induced esophageal injury, J Clin Gastroenterol, 38, 484, 10.1097/01.mcg.0000129058.69524.90 · DOI
  95. Rabar, 2004, Doxycycline-induced photo-onycholysis, J Travel Med, 11, 386, 10.2310/7060.2004.19210 · DOI
  96. Carroll, 2003, Doxycycline-induced photo-onycholysis, J Drugs Dermatol, 2, 662
  97. Passier, 2004, Photo-onycholysis associated with the use of doxycycline, BMJ, 329, 265, 10.1136/bmj.329.7460.265 · DOI
  98. Habif, 2006, Doxycycline-induced phototoxicity, N Engl J Med, 355, 182, 10.1056/NEJMicm050829 · doi:10.1056/nejmicm050829
  99. Ghozzi, 2008, [Benign intracranial hypertension induced by doxycycline], Tunis Med, 86, 510
  100. Tabibian, 2009, Doxycycline-induced pseudotumor cerebri, South Med J, 102, 310, 10.1097/SMJ.0b013e31818f98f0 · doi:10.1097/smj.0b013e31818f98f0
  101. Chan, 2005, Doxycycline and intracranial hypertension, Neurology, 64, 765, 10.1212/WNL.64.4.765-a · doi:10.1212/wnl.64.4.765-a
  102. Friedman, 2004, Doxycycline and intracranial hypertension, Neurology, 62, 2297, 10.1212/WNL.62.12.2297 · doi:10.1212/wnl.62.12.2297
  103. Robles, 2008, Severe drug hypersensitivity reaction in a young woman treated with doxycycline, Dermatology, 217, 23, 10.1159/000119753 · DOI
  104. Sabatine, 2007, Case records of the Massachusetts General Hospital. Case 36-2007. A 31-year-old woman with rash, fever, and hypotension, N Engl J Med, 357, 2167, 10.1056/NEJMcpc079030 · DOI
  105. Gul, 2008, Doxycycline-induced fixed drug eruption, J Dermatolog Treat, 19, 126, 10.1080/09546630701759561 · doi:10.1080/09546630701759561
  106. Jamet, 2008, Doxycycline-induced Sweet’s syndrome, Eur J Dermatol, 18, 595
  107. Izzedine, 2004, Doxycycline, gastrointestinal bleeding, and thrombotic microangiopathy, Am J Hematol, 77, 319, 10.1002/ajh.20174 · doi:10.1002/ajh.20174
  108. Knox-Macaulay, 2004, Acute thrombotic thrombocytopenic purpura following doxycycline treatment of Chlamydia pneumoniae infection in a patient with dermatomyositis, Clin Lab Haematol, 26, 147, 10.1111/j.1365-2257.2004.00594.x · doi:10.1111/j.1365-2257.2004.00594.x
  109. Selimoglu, 2003, Autoimmune hepatitis triggered by Brucella infection or doxycycline or both, Int J Clin Pract, 57, 639, 10.1111/j.1742-1241.2003.tb10577.x · doi:10.1111/j.1742-1241.2003.tb10577.x
  110. Ramsakal, 2007, Images in clinical medicine. Lingua villosa nigra, N Engl J Med, 357, 2388, 10.1056/NEJMicm065655 · doi:10.1056/nejmicm065655
  111. Cac, 2007, Stevens-Johnson syndrome induced by doxycycline, Cutis, 79, 119
  112. Lehembre, 2007, Stevens-Johnson syndrome due to lymecycline, Ann Dermatol Venereol, 134, 461, 10.1016/S0151-9638(07)89214-3 · doi:10.1016/s0151-9638(07)89214-3
  113. AFSSAPS, 2008, Recommendations of good clinical practice on the treatment of acne, Ann Dermatol Venereol, 135, S137
  114. Dréno, 2004, European recommendations on the use of oral antibiotics for acne, Eur J Dermatol, 14, 391
  115. Ochsendorf, 2010, Minocycline in acne vulgaris: benefits and risks, Am J Clin Dermatol, 11, 327, 10.2165/11319280-000000000-00000 · DOI

Cited by

See all 61

Metadata

Authors
Lebrun-Vignes, B., Kreft-Jais, C., Castot, A., Chosidow, O., & the French Network of Regional Centers of Pharmacovigilance
Venue
British Journal of Dermatology
Published
2012-05-25
Volume
166
Issue
6
Pages
1333-1341
ISSN
0007-0963
Cited by
61
References
0
Language
en
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 1194 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literature. https://app.cochat.ai/papers/10.1111/j.1365-2133.2012.10845.x
The paper
Lebrun-Vignes, B., Kreft-Jais, C., Castot, A., Chosidow, O., & the French Network of Regional Centers of Pharmacovigilance. (2012). Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literature. British Journal of Dermatology. https://doi.org/10.1111/j.1365-2133.2012.10845.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.